肝再生
肝细胞
再生(生物学)
肝损伤
肝细胞学
生物
内分泌学
细胞生物学
肝星状细胞
内科学
癌症研究
医学
生物化学
体外
肝脏代谢
作者
Juanjuan Li,Yinghong Zheng,Zhenzhen Duan,Qingye Zeng,Jin Qu,Jincheng Zhang,Jiao Liu,Wenlong Shang,Xixi Tao,Tingting Yu,Xinzhi Li,Lifu Wang,Liming Yang,Deping Kong,Ying Yu
标识
DOI:10.1097/hep.0000000000001020
摘要
Background and aims: The liver possesses a remarkable regenerative capacity in response to injuries or viral infections. Various growth factors and cytokines are involved in regulating liver regeneration. Prostaglandin (PG) D 2 , a pro-resolution lipid mediator, is the most abundant hepatic prostanoid. However, the role of PGD 2 in the injury-induced liver regeneration remains unclear. Approach and results: Two-thirds partial hepatectomy (70% PH), massive hepatectomy (85% resection), and carbon tetrachloride-induced chronic injury were performed in mice to study the mechanisms of live regeneration. Hepatic PGD 2 production was elevated in mice after PH. Global deletion of D prostanoid receptor (DP) 1, but not DP2, slowed PH-induced liver regeneration in mice, as evidenced by lower liver weight to body weight ratio, less Ki67 + hepatocyte proliferation, and G2/M phase hepatocytes. Additionally, DP1 deficiency specifically in resident Kupffer cells (KCs), and not in endothelial cells or hepatic stellate cells, retarded liver regeneration in mice post-PH. Conversely, the overexpression of exogenous DP1 in KCs accelerated liver regeneration in mice. Mechanistically, DP1 activation promoted Wnt2 transcription in a PKA/CREB-dependent manner in resident KCs and mediated hepatocyte proliferation through Frizzled8/β-catenin signaling. Adeno-associated virus vector serotype 8 (AAV8)-mediated Frizzled8 knockdown in hepatocytes attenuated accelerated liver regeneration in KC-DP1 transgenic mice post-PH. Treatment with the DP1 receptor agonist BW245C promotes PH-induced liver regeneration in mice. Conclusions: DP1 activation mediates crosstalk between KCs and hepatocytes through Wnt2, and facilitates liver regeneration. Hence, DP1 may serve as a novel therapeutic target in acute and chronic liver diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI